Sipavibart (AZD3152) is a human IgG1 lambda2 monoclonal antibody against SARS-CoV-2. Sipavibart is applicable to research related to COVID-19. The isotype control product for Sipavibart is Human IgG1 lambda2, Isotype Control (HY-P990096)[1].
Molecular Weight:
(144.7 kDa)
Purity:
98.00
CAS Number:
[2768288-97-5]
Target:
SARS-CoV
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
